Reactivation of mutant p53: a new strategy for cancer therapy.
about
Carcinogenesis and cancer prevention: the process and the disease deserve a better understandingTargeting Oncogenic Mutant p53 for Cancer TherapyPathways governing G1/S transition and their response to DNA damageA proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer.Mutant p53 exhibits trivial effects on mitochondrial functions which can be reactivated by ellipticine in lymphoma cells.Complementation of two mutant p53: implications for loss of heterozygosity in cancer.Wild type p53 reactivation: from lab bench to clinic.TRAIL-induced apoptosis is enhanced by heat shock protein 70 expressionThe effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical studyMolecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4: p53 signaling pathway.Reactivation of mutant p53: molecular mechanisms and therapeutic potential.Restoring p53 tumor suppressor activity as an anticancer therapeutic strategy.Early identification of false positives in high-throughput screening for activators of p53-DNA interaction.Mutant p53 melanoma cell lines respond differently to CP-31398-induced apoptosis.The C-terminus of mutant p53 is necessary for its ability to interfere with growth arrest or apoptosis.Killing time for cancer cells.Oligomerization of p53 upon cooperative DNA binding: towards a structural understanding of p53 function.Achilles' heel of cancer?
P2860
Q24801003-CA82CD9B-C6BC-4FF1-9623-E59E1E7845A1Q26770856-2791C260-0FFD-43CD-8B0D-A8ABE42A6572Q28202348-0771EBC5-C0E7-497A-A2CC-B7C5D4F8547AQ33267359-61F6185A-A85E-42D0-AC0B-DACF5F6B6C96Q33755827-3AA261B6-0A7B-4591-809D-E478713F0BFFQ34409021-7480ADDF-4E05-4278-B4F2-9E51257326DAQ35146343-8A053AFC-8FB4-4900-91D5-7ECC31D2568FQ35239558-A25AE0B3-FAF7-4E84-8487-218EDE16840BQ35674823-394BB215-CAE8-4CEB-8462-743C8BD332A9Q36066191-37181D12-4E5F-4EF4-A79C-24BCF08FB673Q36777373-E471AE41-CA82-4256-A3DD-7B656F6A0A09Q37818291-8A55A28E-6F3A-4206-A532-F42412CA0172Q40271836-BA204575-D686-4B13-A8C5-11F6B0F2B165Q40362071-172FCBEA-644D-4C1A-BD07-4838815BD251Q43718785-1EE9EB71-F359-4A26-A6AC-C03CF016C95AQ46555496-E07ABADE-F4CC-4DD4-A5DE-D0CDE64EA0B4Q47831522-4B0D2F6D-7E6B-4767-B281-FC2EFC3E6693Q59091650-019684F7-3774-4654-8F31-F413F9A613F8
P2860
Reactivation of mutant p53: a new strategy for cancer therapy.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
Reactivation of mutant p53: a new strategy for cancer therapy.
@ast
Reactivation of mutant p53: a new strategy for cancer therapy.
@en
Reactivation of mutant p53: a new strategy for cancer therapy.
@nl
type
label
Reactivation of mutant p53: a new strategy for cancer therapy.
@ast
Reactivation of mutant p53: a new strategy for cancer therapy.
@en
Reactivation of mutant p53: a new strategy for cancer therapy.
@nl
prefLabel
Reactivation of mutant p53: a new strategy for cancer therapy.
@ast
Reactivation of mutant p53: a new strategy for cancer therapy.
@en
Reactivation of mutant p53: a new strategy for cancer therapy.
@nl
P356
P1476
Reactivation of mutant p53: a new strategy for cancer therapy
@en
P2093
L Ryabchenko
T Kawasaki
P304
P356
10.1006/SCBI.1998.0099
P577
1998-01-01T00:00:00Z